Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Analysts are expecting strong growth driven by the robust sales of Lilly's https://deborahqrut056661.ivasdesign.com/58000089/analyzing-eli-lilly-s-q3-results